SI-BONE, INC. Revenues
SI-BONE, INC. (SIBN) reported Revenues of $67.30 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-10.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2021-03-10
- SI-BONE, INC. revenues for the quarter ending 2019-12-31 was $19.81M, a 26.80% increase year-over-year.
- SI-BONE, INC. revenues for the quarter ending 2019-09-30 was $16.18M, a 20.93% increase year-over-year.
- SI-BONE, INC. revenues for the quarter ending 2019-06-30 was $16.32M, a 19.42% increase year-over-year.
- SI-BONE, INC. revenues for the quarter ending 2019-03-31 was $14.99M, a 17.93% increase year-over-year.
- SI-BONE, INC. revenues for fiscal 2019 was $67.30M, a 21.53% increase from fiscal 2018.
- SI-BONE, INC. revenues for fiscal 2018 was $55.38M, a 15.42% increase from fiscal 2017.
- SI-BONE, INC. revenues for fiscal 2017 was $47.98M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2019-12-31 | $19.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $35.99M derived: sum of 2 quarters · filed 2021-03-10 | $52.31M derived: sum of 3 quarters · filed 2021-03-10 | $67.30M 10-K · filed 2021-03-10 |
| 2019-09-30 | $16.18M 10-Q · filed 2019-11-12 | $32.50M derived: sum of 2 quarters · filed 2019-11-12 | $47.49M 10-Q · filed 2019-11-12 | $63.11M derived: sum of 4 quarters · filed 2020-03-11 |
| 2019-06-30 | $16.32M 10-Q · filed 2019-08-07 | $31.31M 10-Q · filed 2019-08-07 | $46.93M derived: sum of 3 quarters · filed 2020-03-11 | $60.31M derived: sum of 4 quarters · filed 2020-03-11 |
| 2019-03-31 | $14.99M 10-Q · filed 2019-05-09 | $30.61M derived: sum of 2 quarters · filed 2020-03-11 | $44.00M derived: sum of 3 quarters · filed 2020-03-11 | $57.66M derived: sum of 4 quarters · filed 2020-03-11 |
| 2018-12-31 | $15.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $29.00M derived: sum of 2 quarters · filed 2020-03-11 | $42.67M derived: sum of 3 quarters · filed 2020-03-11 | $55.38M 10-K · filed 2020-03-11 |
| 2018-09-30 | $13.38M 10-Q · filed 2019-11-12 | $27.04M derived: sum of 2 quarters · filed 2019-11-12 | $39.76M 10-Q · filed 2019-11-12 | $53.52M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $13.66M 10-Q · filed 2019-08-07 | $26.38M 10-Q · filed 2019-08-07 | $40.14M derived: sum of 3 quarters · filed 2019-08-07 | $51.83M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $12.71M 10-Q · filed 2019-05-09 | $26.48M derived: sum of 2 quarters · filed 2019-05-09 | $38.16M derived: sum of 3 quarters · filed 2019-05-09 | |
| 2017-12-31 | $13.77M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $25.45M derived: sum of 2 quarters · filed 2019-03-14 | $47.98M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $11.68M 10-Q · filed 2018-11-29 | $34.21M 10-Q · filed 2018-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |